Underestimation of treatment effect in crossover trials

Area of Science:

• Clinical Trials Methodology
• Cardiovascular Disease Research

Background:

• Crossover trials are preferred for studying cardiovascular diseases like hypertension due to inherent between-subject variability.
• These designs eliminate bias by having each subject serve as their own control.

Purpose of the Study:

• To analyze the potential influences of treatment-by-period interaction on crossover trial outcomes.
• To investigate factors that may lead to underestimation of treatment effects in crossover designs.

Main Methods:

• Analysis of potential influences on crossover trial outcomes.
• Examination of physical carryover effects and external factors impacting trial results.

Main Results:

• Physical carryover effects and inactive agent experiences can minimize differences between treatment periods.
• External influences, such as seasonal changes, can similarly affect lengthy crossover trials.
• The study suggests treatment effects in crossover trials tend to be underestimated.

Conclusions:

• The common perception of exaggerated treatment effects in clinical trial reports may not apply to crossover trials.
• Treatment-by-period interactions can lead to an underestimation of the true treatment effect.